Screening of anti-atherogenic substances from insect resources

Korean Journal of Pharmacognosy

Volumn 35, Issue 3, 2004, Pages 233-238

  Park, Doo Sang ^a   Yoon, Mi Ae ^a   Xu, Ming Zhe ^a   Yu, Hana ^a   Kim, Ju Ryoung ^a   Jeong, Tae Sook ^a   Park, Ho Yong ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

ACAT; Atherosclerosis; Inhibitor; Insect resources; LDL oxidation; Lp PLA2

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; ANTIATHEROGENIC SUBSTANCE; BIOLOGICAL MARKER; CHOLESTEROL ACYLTRANSFERASE; ENZYME INHIBITOR; HEXANE; LIPOPROTEIN; LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2; METHANOL; NATURAL PRODUCT; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL PRODUCT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLATTARIA; COLEOPTERA; DRUG SCREENING; ENZYME INHIBITION; EURYDEMA RUGOSA; EXTRACT; EXTRACTION; FLY; HEMIPTERA; HYMENOPTERA; INFLAMMATION; INSECT; INSECT EXTRACT; ISCHEMIC HEART DISEASE; LARVA; LEPIDOPTERA; LIPID OXIDATION; MYRIAPODA; NEOLIGOCHAETA; NONHUMAN; ODONNATA; ORTHOPTERA; SCORPIONIDA;

EID: 5444249775     PISSN: 02533073     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Glass, C. K. and Witztum, J. L. (2001) Atherosclerosis: The road ahead. Cell 104: 503-516.
2. Lusis, A. J. (2000) Atherosclerosis. Nature 407: 233-241.
3. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 233-241.
4. 2 in vascular disease. (2001) Circ. Res. 89: 298-304.
5. Bays, H. and Stein, E. A. Pharmacotherapy for dyslipidemia - current therapies and future agents. (2003) Expert Opin. Pharmacother. 4: 1901-1938.
6. Prescott, S. M., Zimmerman, G. A., Starforini, D. M., and Mcintyre, T. M. (2000) Platelet activating factor and related lipid mediators. Ann. Rev. Biochem. 69: 419-445.
7. 2 as independent predictor of coronary heart disease. N. Engl. J. Med. 343: 1148-1155.
8. MacPhee, C. H., Moores, K. E., Boyd, H. F., Dhanak, D., Ife, R. J., Leach, C. A., Leake, D. S., Milliner, K. J., Patterson, R. A., Suckling, K. E., Tew, D. G., and Hickey, D. M. (1999) Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. J. Biochem. 338: 479-487.
9. 2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr. Opin. Pharmacol. 1: 121-125.
10. 2: a tagget directed at the atheroslcerotic plaque. Expert Opin. Then Targets 6: 309-413.
11. Chang, T. Y., Chang, C. C. Y., and Cheng, D. (1997) Acylcoenzyme A: cholesterol acyltransferase. Annu. Rev. Biochem. 66: 613-638.
12. Rudel, L. L. (2001) Acyl coenzyme A:cholesterol acyltransferade type 1 and 2: structure and function in atherosclerosis. Curr. opin. lipidol. 12: 121-127.
13. Accad, M., Smith S. J., Newland, D. L., Sanan, D. A., King, L. E. Jr, Linton, M. F., Fazio, S., and Farese, R. V. Jr. (2000) Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J. Clin. Invest. 105: 711-719.
14. Buhman, K. K., Accad, M., Novak, S., Choi, R. S., Wong, J. S., Hamilton, R. L., Turley, S., and Farese, R. V. Jr. (2000) Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nautre Med. 6: 1341-1347.
15. Steinberg, D.; Parthasarathy, S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320, 915-924.
16. Jessup, W. and Kritharides L. (2000) Metabolism of oxidized LDL by macrophages. Curr. Opin. lipidol., 11: 473-481.
17. Bjorkhem, I., Henriksson-Freyschuss, A., Breuer, O., Diczfelusy, U. Berglund, L., and Henriksson, P (1991) The antioxidant butylated hydroxytoluene protects against atherosclerosis. Artenoscler. Thromb. 11: 15-22.
18. Erickson, S. K., Shrewsbury, M. A., Brooks, C., and Meyer, D. J. (1980) Rat liver acyl coemzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro. J. Lipid Res. 21: 930-941.
19. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
20. Brecher, P. and Chan, C. (1980) Properties of Acyl-CoA: cholesterol acyltransferase in aortic mictosomes from atherosclerotic rabbit. Biochim. Biophys. Acta 617: 458-471.
21. Jeong, T. S., Kim, S. U., Son, K. H., Kwon, B. M., Kim, Y. K., Choi, M. U., and Bok, S. H. (1995) GERI-BP001 compounds, new inhibitors of Acyl-CoA:cholesterol acyltransferase from Aspergillus fumigatus F37. I. Production, isolation, and physico-chemical and biological properties. J. Antibiotics 48: 751-756.
22. Cho, K. H., An, S. J., Lee, W. S., Paik, Y. K., Kim, Y. K., and Jeong. T. S. (2003) Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation. Biochem. Biophysic. Res. Comm. 309: 864-872.
23. Havel, R. J., Edger, H. A., and Bradgon, J. H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
24. 2 Bioorg. Med. Chem. Lett., 10: 2557-2561.
25. 2 inhibitor. Kor. J. Pharmacogn. 34: 100-108.
26. 2. Bioorg. Med. Chem. Lett., 11: 1925-1929.
27. Ann, B. T., Lee, S., Lee, S. B., Lee, E. S., Kim, J. G., Bok, S. H., and Jeong, T. S. (2001) Low-density lipoprotein-antioxidant constituents of Saururus chinensis. J. Nat. Prod. 64: 1562-1564.
28. Xu, M.-Z., Lee, W. S., Kim, M. J., Park, D.-S., Yu, H., Tian, G.-R., Jeong, T.-S., and Park, H.-Y. (2004) Acyl-CoA: cholesterol acyltransferase inhibitory activities of fatty acid amides isolated from Mylabris phalerate Pallas Bioorg. Med. Chem. Lett., 14: 4277-4280.